STRONG IODINE SOLUTION- strong iodine solution solution/ drops 
Safecor Health, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

NDC 48433-230-15
STRONG IODINE SOLUTION, U.S.P.
(Lugol's Solution)

FOR ORAL USE ONLY

DESCRIPTION

Iodine 5g, potassium iodide 10g, in enough purified water to make 100 ml.

INDICATIONS

Strong Iodine Solution, containing 5 percent of iodine and 10 percent of potassium iodide, is employed in the prophylaxis of simple and colloid goiters and in the treatment of exophthalmic goiter.  It can be used alone as a preoperative preparation but is now most commonly used concomitantly with propylthiouracil and other antithyroid drugs.  When used with these drugs, Strong Iodine Solution produces involution of the hyperplastic gland thus making a less triable and vascular gland for thyroidectomy.  In addition, it has an additive antithyroid action that helps make the patient enthyroid faster than if the antithyroid drugs were used alone.

CONTRAINDICATIONS

The use of iodides may be contraindicated in patients with tuberculosis because it is believed they may cause a breakdown of healing lesions.  The use of iodides is contraindicated in patients with iododerma, laryngeal edema, and swelling of salivary glands or increased salivation upon previous exposure to iodides.  Strong Iodine Solution is ineffective in the treatment of postoperative thyroid crisis.

PRECAUTIONS

Iodine therapy does not completely control the manifestations of hyperthyroidism and after a variable period of time, the beneficial effects wear off. With continued administration of the drug, the hyperthyroidism may return in its initial intensity or become even more severe than it was at first. Measurements of the protein-bound iodine or of the uptake of radioiodine are rendered useless if iodine is given.

WARNINGS

Prolonged therapy may cause iodism.  USE IN PREGNANCY:  The drug readily crosses the placental barrier and may affect the fetus if used during pregnancy.

ADVERSE REACTIONS

Ingestion of large quantities of Strong Iodine Solution may cause abdominal pain, nausea, vomiting and diarrhea. Average doses may cause skin rash.

DOSAGE

Strong Iodine Solution is for oral use only.  The usual dosage of Strong Iodine Solution is 2 to 6 drops (0.1 to 0.3 ml) three times daily taken in water after meals for two or three weeks prior to operation. In thyroid crisis the dosage is 1 ml three times a day.

HOW SUPPLIED

Bottles of 14 ml, amber glass with lined plastic closures. Accompanying each bottle is a glass dropper which should be used when the solution is ready to be dispensed to minimize any loss of free iodine through the bulb of the dropper.

STORAGE

Store at room temperature

Rx only

SAFECOR HEALTH, LLC
WOBURN, MA 01801

230-02
Rev 05/2019

———Principal Display Panel———

Do Not Use in Eyes

NDC 48433-230-15
Rx only

SAFECOR
HEALTH

Strong Iodine
Solution U.S.P.
(Lugol's Solution)

NET CONTENTS 14 mL

Product Label
STRONG IODINE SOLUTION 
strong iodine solution solution/ drops
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:48433-230
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
IODINE (UNII: 9679TC07X4) (IODINE - UNII:9679TC07X4) IODINE700 mg  in 1 mL
POTASSIUM IODIDE (UNII: 1C4QK22F9J) (IODIDE ION - UNII:09G4I6V86Q) IODIDE ION1400 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:48433-230-1514 mL in 1 BOTTLE; Type 0: Not a Combination Product09/20/2008
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other09/20/2008
Labeler - Safecor Health, LLC (828269675)
Establishment
NameAddressID/FEIBusiness Operations
Safecor Health, LLC078805287manufacture(48433-230)

Revised: 1/2022
Document Id: 2c84b0d0-e460-45d9-abad-f7bfb2a561b9
Set id: ec12b0ab-8fee-4b4f-a6e7-349f60a6f3e0
Version: 2
Effective Time: 20220126
 
Safecor Health, LLC